Evidence map›Paper›PMID 27640169›Full record

ReviewCurrent diabetes reports2016

Salivary Amylase: Digestion and Metabolic Syndrome.

Catherine Peyrot des Gachons, Paul A S Breslin

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 3 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 3 syntheses or guidelines pooled it, 255 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Potential of Saliva in Stroke Patients: A Review.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Article
  10. Clarified açaí (Euterpe oleracea Martius) exerts protective effects against methylmercury toxicity in salivary glands and total saliva.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Characterization ofInsects · 2026
    Article
  15. Article
  16. Review
  17. Article
  18. The Potential ofDrug design, development and therapy · 2026
    Review
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Catherine Peyrot des GachonsMonell Chemical Senses Center, Philadelphia, PA, USA.
Paul A S BreslinMonell Chemical Senses Center, Philadelphia, PA, USA. breslin@aesop.rutgers.edu.
Monell Chemical Senses Center · US

Funding

Role of Metabolic Sensing in Human Sweet TasteR01DC014286 · NIDCD · MONELL CHEMICAL SENSES CENTER · PI BRESLIN, PAUL A. S, MARGOLSKEE, ROBERT F. · 2016 to 2020
$1.9M
NIDCD NIH HHS R01 DC014286
6 · The paper itself

Abstract

Salivary amylase is a glucose-polymer cleavage enzyme that is produced by the salivary glands. It comprises a small portion of the total amylase excreted, which is mostly made by the pancreas. Amylases digest starch into smaller molecules, ultimately yielding maltose, which in turn is cleaved into two glucose molecules by maltase. Starch comprises a significant portion of the typical human diet for most nationalities. Given that salivary amylase is such a small portion of total amylase, it is unclear why it exists and whether it conveys an evolutionary advantage when ingesting starch. This review will consider the impact of salivary amylase on oral perception, nutrient signaling, anticipatory metabolic reflexes, blood sugar, and its clinical implications for preventing metabolic syndrome and obesity.

Indexed as

AmylasesBlood GlucoseHumansMetabolic SyndromeObesitySalivaStarchAmylasesBlood GlucoseStarchAMY1 copy number variationGlucose homeostasisInsulinMetabolic syndromeSalivary amylaseStarch digestion

Identifiers

PMID27640169
PMCPMC6825871
OpenAlexW2519637212

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.